This white paper details the CAS Biomedical Knowledge Graph and shows how it was used in drug discovery for COVID-19.
CAS IP Research: Opportunities for Accelerating Innovation and Mitigating Risk at the Nexus of Intellectual Property and R&D
This CAS whitepaper explores the transformation of IP and R&D, where organizations apply IP insights to accelerate breakthroughs and identify potential risks to commercialization earlier in the product lifecycle.
Accelerating Discovery: COVID-19 Vaccine Breakthroughs and their Future Impact
This whitepaper explores innovative research and technologies that played crucial roles in Covid-19 vaccine development.
Predicting New Chemistry: Impact of High-Quality Training Data on Prediction of Reaction Outcomes
Scientists at Bayer expand their understanding into new, useful chemistry by improving the predictive power of a synthesis planning model with scientist-curated reactions from CAS.
Ammonium Nitrate Safety
This in-depth CAS Report discusses the chemical properties of ammonium nitrate, its hazards and safety rules, and provides a useful resource for those involved in the handling and storage of this compound.
How to Maximize the Strategic Value of Formulations Data in Pharma
This whitepaper discusses how pharmaceutical companies can maximize the strategic value of formulations data to shorten development times, stay ahead of competition, and position themselves for success.
Hydrogen Fuel - Insights into a Growing Market
Download this in-depth CAS Market Report to gain insight into the evolution of hydrogen fuel technology, the global innovation landscape, key market trends and potential applications and opportunities.
Emerging Trends in Drug Delivery
Emerging Trends in Drug Delivery is a CAS whitepaper which highlights four technologies that have shown particular growth in recent years and are expected to be key innovation areas in the future.
Five Overlooked IP Gaps That Can Derail Your Innovation Strategy
Download this CAS whitepaper and learn five often overlooked IP gaps that can hinder innovation strategy.